Outlook Therapeutics Inc (OTLK)
8.19
-0.31
(-3.65%)
USD |
NASDAQ |
May 07, 16:00
8.19
0.00 (0.00%)
After-Hours: 16:15
Outlook Therapeutics Cash and Short Term Investments (Quarterly): 10.36M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 10.36M |
September 30, 2023 | 23.39M |
June 30, 2023 | 33.71M |
March 31, 2023 | 43.63M |
December 31, 2022 | 52.34M |
September 30, 2022 | 17.40M |
June 30, 2022 | 26.02M |
March 31, 2022 | 58.42M |
December 31, 2021 | 70.15M |
September 30, 2021 | 14.48M |
June 30, 2021 | 19.69M |
March 31, 2021 | 37.17M |
December 31, 2020 | 5.568M |
September 30, 2020 | 12.54M |
June 30, 2020 | 23.95M |
March 31, 2020 | 4.653M |
December 31, 2019 | 1.334M |
Date | Value |
---|---|
September 30, 2019 | 8.016M |
June 30, 2019 | 14.03M |
March 31, 2019 | 0.1555M |
December 31, 2018 | 0.2277M |
September 30, 2018 | 1.717M |
June 30, 2018 | 11.80M |
March 31, 2018 | 5.936M |
December 31, 2017 | 13.84M |
September 30, 2017 | 3.186M |
June 30, 2017 | 0.1399M |
March 31, 2017 | 0.081M |
December 31, 2016 | 2.078M |
September 30, 2016 | 2.352M |
June 30, 2016 | 13.56M |
March 31, 2016 | 2.842M |
December 31, 2015 | 10.81M |
September 30, 2015 | 9.071M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.334M
Minimum
Dec 2019
70.15M
Maximum
Dec 2021
25.10M
Average
19.69M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Cutera Inc | 143.61M |
Actinium Pharmaceuticals Inc | 84.06M |
GT Biopharma Inc | 13.97M |
Karyopharm Therapeutics Inc | 191.44M |
Marinus Pharmaceuticals Inc | 150.29M |